BOSTON, Aug. 14, 2023 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of. -Today at 08:02 am- MarketScreener
Summer's here; shake it up, Seattle and King County voters seattletimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seattletimes.com Daily Mail and Mail on Sunday newspapers.
NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.